• Dovitinib (TKI-258): Potent Multitargeted RTK Inhibitor for

  2026-04-28

  Dovitinib (TKI-258, CHIR-258) is a multitargeted receptor tyrosine kinase inhibitor with nanomolar potency against FLT3, c-Kit, FGFR, VEGFR, and PDGFR. It suppresses cell proliferation and induces apoptosis in multiple cancer models by inhibiting ERK and STAT signaling. Dovitinib is widely used in RTK-driven cancer research due to its reproducibility and robust mechanistic action.

• Grazoprevir Hydrate: Optimizing HCV NS3/4A Protease Assays

  2026-04-28

  Grazoprevir hydrate (MK-5172 hydrate) enables robust, reproducible hepatitis C virus (HCV) NS3/4A protease inhibition in both translational and clinical research settings. Explore advanced protocol enhancements, troubleshooting strategies, and real-world data to boost your hepatitis C workflows—especially for challenging patient cohorts and resistance scenarios.

• Spartin as a Lipid Transfer Protein in Lipid Droplet Turnove

  2026-04-27

  This study uncovers the molecular function of spartin (SPG20) as a lipid transfer protein required for lipid droplet (LD) degradation in cells. The authors demonstrate that spartin’s senescence domain mediates lipid binding and transfer, and that this activity is essential for efficient LD turnover—a process with implications for cellular energy regulation and neurodegenerative disease.

• Dual Enzyme-Responsive Zwitterionic Peptides for Cancer Sele

  2026-04-27

  This study introduces a zwitterionic peptide amphiphile that achieves high cancer selectivity through dual enzyme responsiveness and intralysosomal self-assembly. The approach leverages differential enzymatic expression in cancer versus normal cells, providing a promising pathway for targeted peptide-based chemotherapeutics with minimal off-target effects.

• AG-490 (JAK2/EGFR inhibitor): Data-Driven Solutions for Canc

  2026-04-26

  This article provides an evidence-based guide for leveraging AG-490 (JAK2/EGFR inhibitor, SKU A4139) in complex cancer and immunology workflows. Drawing on recent peer-reviewed research and best-practice comparisons, we address practical challenges in JAK-STAT pathway analysis and macrophage polarization assays. Scientists will find actionable, literature-backed protocol guidance and credible vendor recommendations tailored to real-world lab needs.

• High-Throughput BBB Model Integrates MDR1 Cells and Lysosoma

  2026-04-25

  This study presents a robust in vitro blood-brain barrier (BBB) model using LLC-PK1-MOCK/MDR1 cells, significantly advancing physiologically relevant CNS drug permeability prediction. By correcting for lysosomal trapping, the model enhances accuracy and utility in early-stage CNS drug development workflows.

• One-step TUNEL FITC Apoptosis Detection Kit: Precision Workf

  2026-04-24

  Harness the One-step TUNEL FITC Apoptosis Detection Kit for highly sensitive, reproducible apoptosis quantification in both tissue sections and cultured cells. This guide unpacks protocol enhancements, real-world troubleshooting, and innovative use-cases in neurodegeneration and cancer research—translating bench findings into actionable workflows.

• Phenylmethanesulfonyl Fluoride: Strategic Safeguard in Trans

  2026-04-24

  This article explores the mechanistic and strategic imperatives of Phenylmethanesulfonyl fluoride (PMSF) in translational research, contextualizing its serine protease inhibition with recent breakthroughs in placental biology. By weaving molecular rationale, experimental protocols, and workflow guidance, it empowers researchers to elevate reproducibility, especially in complex cell signaling and clinical sample workflows.

• Applied Resiniferatoxin (RTX) Workflows for Analgesia Resear

  2026-04-23

  Harness the ultra-potency of Resiniferatoxin (RTX) to dissect pain mechanisms and achieve long-lasting sensory neuron desensitization. This guide details experimental protocols, troubleshooting, and advanced applications, empowering researchers to optimize analgesic studies using RTX's unique TRPV1-targeting properties.

• Neem Leaf Extract: Mechanisms of Anti-Aging from Yeast to Hu

  2026-04-23

  Dang et al. (2024) demonstrate that neem leaf extract (NLE) extends lifespan and enhances oxidative stress resistance in yeast and reduces senescence markers in human cells. Their cross-species, multi-omics approach uncovers catalase-mediated regulation of oxidative stress as a key mechanism, providing mechanistic evidence for traditional claims of neem’s anti-aging benefits.

• Isoprinosine (SKU C4417): Data-Driven Immunomodulation in Vi

  2026-04-22

  This article provides evidence-based guidance for leveraging Isoprinosine (SKU C4417) in immunomodulation and viral inhibition workflows. Using real laboratory scenarios, we examine how Isoprinosine supports reproducible, quantitative results in cell-based assays and address common vendor selection challenges. The discussion is grounded in recent literature and practical experience with APExBIO's quality standards.

• TMEM16F Lipid Scrambling: A New Checkpoint in Ferroptosis an

  2026-04-22

  Yang et al. uncover TMEM16F-mediated lipid scrambling as a critical suppressor of ferroptosis, showing its inhibition not only heightens ferroptotic cell death but also enhances antitumor immune responses and synergy with PD-1 blockade. This mechanistic insight advances our understanding of plasma membrane remodeling during ferroptosis and suggests new therapeutic strategies at the intersection of oxidative stress regulation and immunotherapy.

• Omeprazole (A2845): Protocols for H+,K+-ATPase Inhibition St

  2026-04-21

  Omeprazole (SKU A2845) is a potent H+,K+-ATPase inhibitor designed for research applications in gastric acid secretion and antiulcer activity workflows. This product is not intended for diagnostic or clinical use, and should be handled following strict laboratory protocols to ensure reproducibility and data integrity.

• Targeting Pancreatic Fibrosis: MFGE8-ANXA1-SMAD2/3 Pathway I

  2026-04-21

  A recent study delineates how umbilical cord-derived mesenchymal stem cells (UCMSCs) and their extracellular vesicles alleviate pancreatic fibrosis in chronic pancreatitis by modulating the MFGE8-dependent ANXA1-SMAD2/3 axis. This mechanistic advance underpins the development of cell- and nanomedicine-based antifibrotic therapies and offers new experimental avenues for pancreatic function research.

• MK 0893: Optimizing Glucagon Receptor Antagonist Workflows

  2026-04-20

  MK 0893 is a potent, selective glucagon receptor antagonist designed for robust inhibition of cAMP production and translational diabetes research. This article walks through advanced experimental workflows, troubleshooting strategies, and practical insights for maximizing the translational impact of MK 0893 across cell-based and in vivo models.

451 records 20/31 page Previous Next First page 上5页 1617181920 下5页 Last page